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Objectives: The technique of choice for myocardial revascularization in elderly
patients remains a debated issue. We evaluated the potential advantages of the use
of left internal thoracic artery-radial artery composite grafts compared with con-
ventional coronary artery bypass grafts in elderly patients.
Methods: We prospectively enrolled 160 patients aged more than 70 years sched-
uled to undergo isolated myocardial revascularization. Patients were assigned at
random to group 1, 80 patients undergoing total arterial revascularization (left
internal thoracic artery on left anterior descending coronary artery plus radial
artery), or group 2, 80 patients undergoing standard coronary artery bypass graft
surgery (left internal thoracic artery on left anterior descending coronary artery plus
saphenous veins). The radial artery was used in all cases as a composite Y-graft.
Results: Preoperative characteristics and risk factors (EuroSCORE: group 1  7.9
vs group 2  8.1), number of grafted coronary vessels (group 1  2.4 vs group 2
 2.5), aortic crossclamping time (group 1  37  7 minutes vs group 2  38 
7 minutes), ventilation time (group 1 22 12 hours vs group 2 23 11 hours),
intensive care unit stay (group 1  39  10 hours vs group 2  40  9 hours), and
hospital mortality (group 1 3.8% vs group 2 5%) were comparable between the
groups. Comparison between the 2 groups in terms of early postoperative compli-
cations showed a higher incidence of cerebrovascular accidents in group 2 (group 1
 0 patients vs group 2  4 patients, 5%). At a mean follow-up of 16  3 months,
patients in group 1 showed superior clinical results with a lower incidence of graft
occlusion (group 1  2 vs group 2  11; P  .06) and angina recurrence (group 1 
2 patients vs group 2 12 patients; P .03). Multivariate analysis identified saphenous
vein grafts as independent predictors for graft occlusion and angina recurrence.
Conclusions: Left internal thoracic artery-radial artery composite grafts proved to be
a safe procedure in elderly patients. It improved the clinical outcome, providing a
significantly higher graft patency rate and a lower incidence of late cardiac events.
Asteadily increasing number of patients aged more than 70 yearsare undergoing coronary artery bypass graft (CABG) surgery.1,2Many authors have reported improved outcomes and beneficialeffects of surgical innovations, such as multivessel off-pumpcoronary surgery, performed in this subset of high-risk patients.3-6Nevertheless, most surgeons still consider saphenous vein grafts
(SVGs) the conduits of choice in elderly patients despite the proven benefits of
internal thoracic arteries on long-term outcome. Concerns about excessive surgical
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invasiveness of arterial conduit harvesting and reduced life
expectancy have hindered the diffuse use of arterial grafting
in this high-risk subset of patients.
The use of the radial artery (RA) is progressively gaining
popularity after its revival by Acar and colleagues and the
favorable reports of several centers7-9 describing its use as a
composite Y/T-graft with the left internal thoracic artery
(LITA). We therefore prospectively evaluated the clinical
outcome of elderly patients undergoing total arterial revas-




From October 2000 to January 2002, 160 patients aged more than
70 years and scheduled for on-pump isolated myocardial revascu-
larization were prospectively enrolled after providing informed
consent for the operation. The patients were then randomly as-
signed to group 1 (80 patients undergoing total arterial myocardial
revascularization with composite LITA-RA grafts) or group 2 (80
patients undergoing conventional CABG surgery with LITA on
left anterior descending [LAD] coronary artery and additional
SVGs).
Exclusion criteria for enrollment included age less than 70
years of age, single-vessel disease, emergency operations, con-
comitant procedures other than coronary surgery, LV ejection
fraction less than 20%, Euroscore greater than 10, and the presence
of a positive Allen’s test. The institutional review board approved
the study protocol.
Patients undergoing RA harvesting were assessed with respect
to their nondominant hand circulation by means of the Allen’s test
and oximetric plethysmography.
Surgical Strategy
Radial artery Y/T end-to-side anastomosis was performed on the
fascial side of the LITA with an 8-0 polypropylene running suture
before cardiopulmonary bypass institution. We previously de-
scribed our technique for the arrangement of composite arterial
grafts according to target stenosis and coronary vessels anatomy.10
In particular, in this subset of patients, we used only configuration
types 2 and 3. In configuration type 2, the RA was anastomosed
end-to-side to the in situ LITA in a Y/T-graft fashion, whereas in
configuration type 3, the RA was first divided into 2 segments and
then anastomosed end-to-side on the LITA in a double Y-graft
fashion. The RA and the SVGs were routinely used to bypass
native coronary vessels with a target stenosis of at least 70%,
whereas a coronary artery stenosis of 60% was considered to be
the threshold value when using the LITA.
Two surgeons performed all of the operations in the present
study and were equally represented in both the SVG and LITA-RA
groups.
Postoperative Medications
In patients scheduled to receive the RA grafts, oral diltiazem was
given the day before operation at a dose of 60 mg every 8 hours.
Intravenous diltiazem infusion (mean dose: 0.5-1.5 g · kg · min)
was administered throughout the operation and during the first 48
hours after surgery. Thereafter, diltiazem oral therapy (120 mg/
day) was continued for at least 6 months.
Follow-up
Follow-up visits were performed at 1, 6, and 12 months. Addi-
tional clinical data were collected from patients’ cardiologists and
home physicians. We evaluated the outcome of the patients en-
rolled in the present study with respect to early postoperative
complications (short-term), hospital mortality, and occurrence of
late cardiac-related events (recurrence of angina/myocardial in-
farction, graft occlusion, need of percutaneous transluminal coro-
nary angioplasty [PTCA] reintervention, and death). At angiogra-
phy, graft patency was defined according to Fitzgibbon
classification, that is, grade A (unimpaired graft run-off), grade B
(reduced graft caliber 50% of the grafted coronary artery), and
grade C (occluded graft).
Statistical Analysis
The 2 test was used to analyze preoperative and postoperative
discrete variables, and the unpaired t test or the Mann-Whitney test
was used for continuous variables (expressed as mean  SD).
Multivariate analysis was performed using the Cox regression
model for angina recurrence (time-dependent variable), and mul-
tivariate stepwise logistic regression was used for graft occlusion
(time-independent variable). Survival curves were calculated with
the Kaplan-Meier method. SPSS software was used for statistical
analysis (SPSS 11.5, SPSS Inc, Chicago, Ill).
Preoperative and Perioperative Data
There were no significant differences between the groups in the
preoperative variables, such as age (group 1: 77.3  3 years vs
group 2: 76.8 2 years, P .217), female gender (group 1: 43.7%
vs group 2: 46.2%, P  .874), and preoperative risk factors
(EuroSCORE: group 1  7.9  2.1 vs group 2: 8.1  2.5, P 
.585); in particular, the prevalence of diabetes was 48.7% and 45%
in groups 1 and 2, respectively. Five patients initially randomized
in group 1 were excluded from the study because of a positive
Allen test (3 patients) and significant atherosclerotic lesions of the
RA (2 patients). However, a minimal atherosclerotic wall involve-
ment of the RA did not jeopardize its use.
Double-vessel disease was observed in 36 patients (45%) in
group 1 and in 38 patients (47.5%) in group 2 (P  .87), and
triple-vessel disease was found in 39 patients (48.7%) in group 1
and in 37 patients (46.2%) in group 2 (P  .87). Moreover, 5
patients (6.2%) in groups 1 and 2 had left main stem stenosis (P 
.74). Patients in both groups demonstrated a similar distribution of
target coronary vessels (group 1: LITA-LAD  80, RA-diagonal
 12, RA-circumflex  57, RA-right coronary artery  43 vs
group 2: LITA-LAD  80, SVG-diagonal  14, SVG-circumflex
 62, SVG-right coronary artery  44) and received a similar
number of graft anastomoses (mean number of anastomoses in
group 1: 2.4  0.5 vs group 2: 2.5  0.2, P  .408). The LITAs
and the SVGs were used as single grafts in the majority of cases
(LITA: 80/80 anastomoses, 100%; SVG: 196/200 anastomoses,
98%), whereas the RA was more extensively used for sequential
anastomoses (32/192 anastomoses, 16.6%). Table 1 illustrates
additional intraoperative and perioperative data.
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The early postoperative outcome was similar between the groups
in terms of mechanical ventilation time, intensive care unit stay,
and hospital postoperative stay (Table 1). Patients in both groups
demonstrated a similar incidence of postoperative complications,
such as atrial fibrillation (group 1: 37.5% vs group 2: 40%, P 
.871), respiratory insufficiency (group 1: 7.5% vs group 2:8.7%,
P  1), renal failure (group 1: 6.2% vs group 2:8.7%, P  .764),
perioperative myocardial infarction (group 1: 1.25% vs group 2:
1.25%, P  .477), sternal wound infection (group 1: 1.25% vs
group 2 :1.25%, P  .477), and reoperation for bleeding (group 1:
2.5% vs group 2: 1.25%, P  1). Conversely, we observed the
occurrence of cerebrovascular accidents only in patients (n  4)
undergoing conventional coronary surgery (group 1: 0% vs group
2: 5%, P  .129). Moreover, 7 patients had wound complications
at the site of saphenous vein harvesting (8.75%), whereas no arm
wound complication was detected in patients who had RA har-
vesting (P  .019), despite a similar prevalence of preoperative
risk factors (eg, diabetes).
Hospital mortality was similar in the 2 groups (Table 1). A total
of 3 patients in each group died of sepsis and multiorgan failure,
and 1 patient in group 2 died of intractable arrhythmia.
Follow-up
We evaluated 76 patients (98%) in group 1 and 76 patients (100%)
in group 2 by means of clinical visits and cycloergometric tests.
Recurrence of angina (defined as chest pain of Canadian Car-
diovascular Society class II or higher) was detected in 2 patients in
group 1 and 10 patients in group 2 (P  .03), new onset of
myocardial infarction (defined as an abnormal increase in cardiac-
specific enzyme values, eg, CK-MB and troponin I) occurred in 1
patient in group 1 and 7 patients in group 2 (P  .06), need of
PTCA reintervention was observed only in patients receiving
SVGs (group 1: 0 patients vs group 2: 8 patients, P .01), and late
mortality was similar between the 2 groups (group 1  2 patients
vs group 2  3 patients; P  .98).
Angiographic evaluation was performed in 89.6% and 88.1%
of hospital survivors in groups 1 and 2, respectively, after a mean
period of 16  3 months. Table 2 provides a detailed outline of
target coronary artery vessels, depicting a similar distribution
between the groups. Angiography demonstrated a graft patency
rate of 100% and 98.5% for the LITA in groups 1 and 2 (Fitzgib-
bon grade A), respectively. RA grade A patency rates (98.6%)
were significantly higher (P  .033) when compared with SVG
grade A patency rates (88.5%). Therefore, 1 RA and 11 SVGs
were classified as Fitzgibbon grade C.
When we performed a multivariate risk factor analysis on the
predictors of late cardiac-related events, the only independent
predictors of recurrent angina and graft occlusion were diabetes,
the use of SVGs, and hyperlipidemia (Figure 1).
Discussion
As the population of patients undergoing coronary surgery steadily
ages, the impact of surgical innovations (eg, total arterial myocar-
dial revascularization) in this high-risk subset of patients needs to
be extensively evaluated. After the revival of the RA as a conduit
for CABG by Acar and colleagues,7 other authors8,9 reported the
favorable impact of this arterial conduit when used as a composite
Y/T-graft with the LITA.
However, despite recent studies demonstrating the beneficial
effects of total arterial grafting in the younger population,10,11
most surgeons still consider SVGs as the conduits of choice for
myocardial revascularization in elderly patients. This is because of
the belief that arterial grafting in elderly patients may be associated
with a higher perioperative morbidity and mortality when com-
pared with younger patients.4
Because both advanced age and the presence of several comor-
bidities12 may significantly affect the quality of the saphenous vein
conduit and the degree of native coronary vessel disease, we
evaluated in a prospective and randomized study the impact of
total arterial revascularization with composite LITA-RA grafts in
elderly patients. As outlined in the Methods section, we adopted
only a few exclusion criteria to minimize the disproportionate
distribution of high-risk patients into 1 particular group, the impact
of selection bias and the effect of randomization.
In our study, patients receiving total arterial revascularization
LITA-RA composite grafts did not show any increase in terms of
perioperative morbidity and mortality when compared with the
conventional group, demonstrating that total arterial grafting can
be safely performed in elderly patients; conversely, the postoper-
ative incidence of leg wound infections (because of an impaired
healing process in this subset of patients) and cerebrovascular
accidents was considerably higher in patients receiving SVGs.
These results highlight the importance of reducing the degree of
ascending aortic manipulation in this high-risk group of patients.
Even if the differences did not reach a significant value, it should
TABLE 2. Angiographic results
Group 1 Group 2
LAD-LITA Evaluated 69 67
Occluded 0 1 (1.4%)
Diag-RA/SVG Evaluated 10 10
Occluded 0 2 (20%)




RCA-RA/SVG Evaluated 37 36
Occluded 0 4 (11.1%)
Group 1, total arterial revascularization; group 2, conventional revascular-
ization. LAD, Left anterior descending; LITA, left internal thoracic artery;
Diag, diagonal; Cx, circumflex artery; RCA, right coronary artery; RA, radial
artery; SVG, saphenous vein graft.
TABLE 1. Intraoperative and perioperative data
Group 1 Group 2 P
No. of grafted vessels* 2.47 0.5 2.52 0.2 .408
Aortic crossclamping time (min)* 37 7 38 7 .368
CPB time (min)* 56 14 70 11 .001
Mechanical ventilation time (h)* 22 12 23 11 .583
ICU stay (h)* 39 10 40 9 .507
Postoperative hospital stay (d)* 7 1 7 2 1
Hospital mortality (%) 3 (3.75%) 4 (5%) 1
Group 1, total arterial revascularization; group 2, conventional revascular-
ization. CPB, Cardiopulmonary bypass; ICU, intensive care unit.
*Values are expressed as mean  SD.
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be noted that all the cerebrovascular accidents occurred in group 2.
We therefore foresee that this difference would become significant
in a larger cohort of patients.
Moreover, the major advantages of total arterial revasculariza-
tion were particularly evident at mid-term: Sixteen months post-
operatively, patients with LITA-RA composite grafts showed a
significantly better clinical outcome with a lower incidence of
angina and myocardial infarction recurrence (angina: group 1  2
patients vs group 2  10 patients, P  .03; myocardial infarction:
group 1 1 patient vs group 2 7 patients, P .06). In addition,
no patient in group 1 needed coronary reintervention, whereas 8
patients in group 2 underwent PTCA (P  .01).
Angiographic evaluation confirmed the clinical results, demon-
strating significantly higher graft patency rates of the RA when
compared with saphenous veins, regardless of the target coronary
arteries.
Multivariate analysis identified SVGs, diabetes, and hyperlip-
idemia as independent predictors for angina recurrence and graft
occlusion. In the Cox regression model, patients receiving SVGs
demonstrated a higher risk of developing angina recurrence (haz-
ard ratio of 2.3). As a consequence, the actuarial event-free sur-
vival was significantly better in patients receiving LITA-RA com-
posite grafts (Figure 2).
Figure 2. Event-free (no recurrence of angina, myocardial infarc-
tion, PTCA reintervention, death) survival curves for patients
undergoing total arterial myocardial revascularization (group 1)
and conventional coronary surgery (group 2). The difference be-
tween the conventional and arterial groups was significant.
Figure 1. Independent predictors of angina recurrence (Cox proportional hazard model, A) and graft occlusion
(multivariate stepwise logistic regression, B) at multivariate analysis. CI, Confidence interval; OR, odds ratio.
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This study confirms the safety and efficacy of total arterial grafting
in elderly patients. Moreover, the randomized comparison clearly
shows that patients receiving total arterial grafting had signifi-
cantly better clinical outcome when compared with patients re-
ceiving SVGs. In the elderly population, the presence of extremely
diseased coronary arteries and poor quality veins may significantly
affect the patency of SVGs. In this subset population, LITA-RA
grafts improve the clinical benefits of coronary surgery.
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Discussion
Dr Brian F. Buxton (Heidelberg, Australia). Dr Muneretto,
thank you for your excellent presentation this morning. I
congratulate you and your colleagues on undertaking this
prospective randomized trial in such an elderly group of
patients.
There are a few exclusions in your entry criteria; there-
fore, the results are widely applicable and of interest to most
adult cardiac surgeons. It should be emphasized, however,
that the follow-up, defined as mid-term, is only 16 months.
The surgical mortality and morbidity are low in both groups,
indicating a very high quality of surgery.
A major strength of this article is the very high propor-
tion of angiograms performed in both groups. If we focus on
the secondary graft patency (non-LITA), there were 1 of 75
radial failures compared with 11 of 100 SVG failures. This
is a very large difference, as you indicated, in your study. It
raises, in my mind, 2 questions.
I noted in your article that the preparation of the RA grafts
was performed very carefully using calcium channel blockers,
and that this was continued into the postoperative period. I am
wondering whether the SVGs were afforded the same level of
protection as the RA grafts because this may be a factor?
Second, were the trial surgeons equally distributed be-
tween the 2 types of surgical groups? For instance, did the
senior surgeons or the more experienced surgeons perform
the operations in the RA composite graft group and the
less-trained surgeons perform the operations in the opposite
group? The reason for raising these issues is that our own
RA patency and clinical outcomes study, which we pre-
sented here last year, showed that there was little difference
between saphenous vein and RA graft patency at 5 years.
A weakness in your study is the inclusion of angina in the
composite end point of event-free survival. Events that you
included were death, reintervention, myocardial infarction, and
angina. Death and reintervention are very robust end points;
however, angina is a very weak end point and when included
in a composite end point carries the same weight as death
during the analysis. Therefore, the conclusion should receive
some skepticism. The last question I ask is if angina was
removed as an end point, would the difference in outcome
between the composite arterial and conventional groups be
significant?
In summary, Mr Chairman, I believe this is a very
important article. I think Dr Muneretto and colleagues’
preliminary data are very impressive. I believe a longer
follow-up will be necessary to provide convincing evidence
of the benefits of these grafts compared with conventional
grafting, to justify the title that this is “the treatment of
choice,” and to convince surgeons to alter their practice.
Thank you very much, and I thank the association and the 2
chairmen, Dr Crawford and Dr David, for the invitation.
Dr Muneretto. Thank you very much, Dr Buxton, for
your kind remarks.
Concerning your first question on whether the SVGs
were treated with the same level of protection as the RA
grafts, both SVGs and RA grafts were harvested by resident
surgeons; however, staff surgeons always evaluated the
quality of the grafts before their use.
SVGs were routinely stored in heparinized saline solu-
tion, whereas, to avoid any damage derived from storage,
the RA (after intraluminal dilatation with papaverine solu-
tion) was maintained in situ until the composite graft anas-
tomosis was performed.
We did not use any calcium channel blocker in patients
receiving SVGs because there is no evidence of beneficial
effects of those drugs on saphenous grafts.
The quality of SVGs obviously affected the patency of
those conduits, but my feeling is that with the increasing age
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of the patient population, the quality of SVGs is progres-
sively worsening, and that this process became particularly
evident in the last few years.
As far as the surgical skill is concerned, there were only 2
surgeons performing operations in this study, and they were
equally active in the arterial conduit and SVG groups. There-
fore, I can exclude that differences in surgeons’ experience and
technical skill could negatively affect results in the SVG group.
Your last question concerning the inclusion of angina in
the composite end point of event-free survival is very in-
teresting. I have to agree with you that angina may be a
weak end point, but its weakness depends on the definition
criteria used.
In our study, very strict criteria were applied, and post-
operative angina was recorded only when patients had post-
operative angina of class II or more (Canadian class) with a
concomitant demonstration of ischemia at myocardial scin-
tigraphy.
Actually, a new onset of myocardial infarction may be
considered a weak point because the definition of myocar-
dial infarction may be weak too.
However, in our study, a new onset of myocardial in-
farction was recorded only in case of significant release of
specific cardiac enzymes, thus reducing the risk of statistical
survey errors.
In addition, the reason why we decided to include angina
as the primary end point of the study, even with some
concern about its weakness, is the fact that angina is the
most important symptom affecting the quality of life of
patients who undergo coronary surgery. In addition, espe-
cially in elderly patients, relief of angina is the primary goal
of coronary surgery; therefore, we believe that angina
should always be considered in the composite end point of
myocardial revascularization.
Finally, to answer your last question, if angina is re-
moved from the composite end point of event-free survival,
the differences in patients’ outcomes between the composite
arterial and the conventional groups still remain significant.
Dr John W. Hammon Jr (Winston-Salem, NC). I also
congratulate the authors for this very nice study and partic-
ularly the zeal required to do a randomized prospective
study. We also share your feelings about all arterial grafting
techniques and that they provide superior patency rates and
neurologic outcomes.
I have 2 questions. To achieve your low pump times and
ischemia times, did you suture the radial grafts to the side of
the internal thoracic artery before instituting bypass? Do
you believe that this technique could lend itself to an off-
pump–type regimen?
Dr Muneretto. Thank you Dr Hammon for your ques-
tions.
Actually, we performed the anastomosis of the composite
graft before the institution of cardiopulmonary bypass to re-
duce pump time. When we have a composite graft with more
than 1 side branch, the RA is sutured first to avoid any storage.
Then, all the side branches (after intraluminal injection of
papaverine) are distally occluded, and the proximal clamp is
removed. Then, the RA and venous cannulation sites are pre-
pared, and cardiopulmonary bypass is instituted.
Your second question deals with a relevant aspect of
arterial revascularization with composite graft. We defi-
nitely believe that the composite graft technique allows
surgeons to easily perform off-pump full arterial revascu-
larization. Composite graft technique, enhancing the length
of the grafts, allows an extensive mobilization of the heart,
reduces the risk of technical pitfalls and, most important,
avoids the need of any aortic manipulation.
Therefore, in our opinion, the composite graft technique
makes off-pump surgery easy and safe when compared with
the standard technique.
Dr Alain F. Carpentier (Paris, France). I rise to con-
gratulate the authors and to answer the question raised by
the discussant regarding the long-term result of the use of
the RA. I introduced the use of the RA before this associ-
ation in the early 1970s, and 3 years later I advised aban-
doning this technique because of the high incidence of
spasm and occluded artery. However, 8 years later, I saw a
patient who was supposed to have an occluded artery post-
operatively, but the artery was fully patent. This is why we
revived the use of the RA. This has been reported by my
pupil Dr Acar.
Now, the reason I remind you of this story is because
spasm is an important component of the operation. We
know that the RA is very different than the anterior de-
scending. So you did not answer the important question
raised by the first discussant with regard to the use of a
calcium antagonism that we advised in the second part of
our experience. Did you use a calcium antagonist? If so,
how long did you use it to explain your good results?
Dr Muneretto. It is a pleasure to discuss this aspect with
you because you pioneered the use of the RA in cardiac
surgery. When we started the extensive use of the RA in our
department, we considered the calcium antagonist treatment
as one of the key issues to achieve good clinical results.
Our protocol for prevention of RA spasm includes pre-
operative treatment 1 week before the operation (diltiazem
120 mL/day orally). At the time of the operation and post-
operatively during the first 48 hours, diltiazem is adminis-
tered by intravenous infusion (0.5-2  · kg · min). Then,
diltiazem is switched to oral administration, and therapy is
continued for at least 6 months.
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